Drug Shortage Report for SCLERODEX
| Report ID | 255263 |
| Drug Identification Number | 02020939 |
| Brand name | SCLERODEX |
| Common or Proper name | DEXTROSE AND SODIUM CHLORIDE |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM CHLORIDE DEXTROSE |
| Strength(s) | 100MG 250MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 50 X 10 mL vial / fiole |
| ATC code | C05BB |
| ATC description | ANTIVARICOSE THERAPY |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-04-21 |
| Actual start date | 2025-04-21 |
| Estimated end date | 2025-07-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-05-02 |
| Company comments | We are currently collaborating with Health Canada’s Drug Shortages Unit to mitigate any market impact. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | [email protected] - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-05-02 | French | Compare |
| v4 | 2025-05-02 | English | Compare |
| v3 | 2025-04-22 | English | Compare |
| v2 | 2025-04-21 | French | Compare |
| v1 | 2025-04-21 | English | Compare |
Showing 1 to 5 of 5